RxDoctor Payments Data

Daniel Coulter, DO

Family Medicine · Lapeer, MINPI 1942657614

Payments from drug & device makers

$16,850in general payments, 2019–2025

Across 981 payments — averaging $17.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$4K
  • AbbVie$2K
  • AstraZeneca$1K
  • Lilly USA, LLC$1K
  • Pfizer$895
  • Novo Nordisk$855
  • plus $7K from 45 others

What the payments were for

  • Consulting fees$2,00012%
  • Food & beverage$14,71887%
  • Education$1321%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,850 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$74,574
Medicare patients
160
Services billed
1,598

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide75$126,651
MounjaroTirzepatide68$112,044
JardianceEmpagliflozin76$107,443
EliquisApixaban67$74,934
TrulicityDulaglutide33$69,781
Trelegy ElliptaFluticasone/Umeclidin/Vilanter51$55,209
OtezlaApremilast12$54,364
XareltoRivaroxaban33$50,047
BiktarvyBictegrav/Emtricit/Tenofov Ala12$44,716
JanuviaSitagliptin Phosphate26$39,803
RybelsusSemaglutide12$30,841
RexultiBrexpiprazole19$27,336
Repatha SureclickEvolocumab15$24,031
MyrbetriqMirabegron32$22,209
VraylarCariprazine Hcl12$18,902

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$1,114$181,825101 claims
Novo NordiskOzempic, Rybelsus$855$157,49387 claims
Boehringer IngelheimJardiance, Synjardy Xr$381$123,11089 claims
PfizerEliquis$895$74,93467 claims
GSKTrelegy Ellipta, Anoro Ellipta$446$66,61568 claims
AmgenOtezla$4,145$54,36412 claims
Johnson & JohnsonXarelto$454$50,04733 claims
GileadBiktarvy$80$44,71612 claims
MerckJanuvia$126$39,80326 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$1,411$28,37340 claims
Otsuka America Pharmaceutical, Inc.Rexulti$446$27,33619 claims
Astellas Pharma US IncMyrbetriq$461$22,20932 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Lapeer

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →